Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 40

1.

New probiotic strains for inflammatory bowel disease management identified by combining in vitro and in vivo approaches.

Alard J, Peucelle V, Boutillier D, Breton J, Kuylle S, Pot B, Holowacz S, Grangette C.

Benef Microbes. 2018 Feb 27;9(2):317-331. doi: 10.3920/BM2017.0097.

PMID:
29488412
2.

Spray-drying process preserves the protective capacity of a breast milk-derived Bifidobacterium lactis strain on acute and chronic colitis in mice.

Burns P, Alard J, Hrdỳ J, Boutillier D, Páez R, Reinheimer J, Pot B, Vinderola G, Grangette C.

Sci Rep. 2017 Feb 24;7:43211. doi: 10.1038/srep43211.

3.

Beneficial metabolic effects of selected probiotics on diet-induced obesity and insulin resistance in mice are associated with improvement of dysbiotic gut microbiota.

Alard J, Lehrter V, Rhimi M, Mangin I, Peucelle V, Abraham AL, Mariadassou M, Maguin E, Waligora-Dupriet AJ, Pot B, Wolowczuk I, Grangette C.

Environ Microbiol. 2016 May;18(5):1484-97. doi: 10.1111/1462-2920.13181. Epub 2016 Jan 26.

PMID:
26689997
4.

Synbiotic approach restores intestinal homeostasis and prolongs survival in leukaemic mice with cachexia.

Bindels LB, Neyrinck AM, Claus SP, Le Roy CI, Grangette C, Pot B, Martinez I, Walter J, Cani PD, Delzenne NM.

ISME J. 2016 Jun;10(6):1456-70. doi: 10.1038/ismej.2015.209. Epub 2015 Nov 27.

5.

Mortality and translocation assay to study the protective capacity of Bifidobacterium lactis INL1 against Salmonella Typhimurium infection in mice.

Zacarías MF, Reinheimer J, Forzani L, Grangette C, Vinderola G.

Benef Microbes. 2014 Dec;5(4):427-36. doi: 10.3920/BM2013.0086.

PMID:
24902954
6.

Understanding immunomodulatory effects of probiotics.

Pot B, Foligné B, Daniel C, Grangette C.

Nestle Nutr Inst Workshop Ser. 2013;77:75-90. doi: 10.1159/000351388. Epub 2013 Aug 29.

PMID:
24107498
7.

Restoring specific lactobacilli levels decreases inflammation and muscle atrophy markers in an acute leukemia mouse model.

Bindels LB, Beck R, Schakman O, Martin JC, De Backer F, Sohet FM, Dewulf EM, Pachikian BD, Neyrinck AM, Thissen JP, Verrax J, Calderon PB, Pot B, Grangette C, Cani PD, Scott KP, Delzenne NM.

PLoS One. 2012;7(6):e37971. doi: 10.1371/journal.pone.0037971. Epub 2012 Jun 27.

8.

Bifidobacteria and subsets of dendritic cells: friendly players in immune regulation!

Grangette C.

Gut. 2012 Mar;61(3):331-2. doi: 10.1136/gutjnl-2011-301476. Epub 2011 Dec 1. No abstract available.

PMID:
22135408
9.

Beneficial effect of probiotics in IBD: are peptidogycan and NOD2 the molecular key effectors?

Macho Fernandez E, Pot B, Grangette C.

Gut Microbes. 2011 Sep 1;2(5):280-6. doi: 10.4161/gmic.2.5.18255. Epub 2011 Sep 1. Review.

PMID:
22067939
10.

Anti-inflammatory capacity of selected lactobacilli in experimental colitis is driven by NOD2-mediated recognition of a specific peptidoglycan-derived muropeptide.

Macho Fernandez E, Valenti V, Rockel C, Hermann C, Pot B, Boneca IG, Grangette C.

Gut. 2011 Aug;60(8):1050-9. doi: 10.1136/gut.2010.232918. Epub 2011 Apr 6. Erratum in: Gut. 2011 Oct;60(10):1444. Fernandez, Elise Macho [corrected to Macho Fernandez, Elise].

PMID:
21471573
11.

Mechanisms involved in alleviation of intestinal inflammation by bifidobacterium breve soluble factors.

Heuvelin E, Lebreton C, Grangette C, Pot B, Cerf-Bensussan N, Heyman M.

PLoS One. 2009;4(4):e5184. doi: 10.1371/journal.pone.0005184. Epub 2009 Apr 17.

12.

Differential crosstalk between epithelial cells, dendritic cells and bacteria in a co-culture model.

Zoumpopoulou G, Tsakalidou E, Dewulf J, Pot B, Grangette C.

Int J Food Microbiol. 2009 Apr 30;131(1):40-51. doi: 10.1016/j.ijfoodmicro.2008.12.037. Epub 2009 Mar 4.

PMID:
19264370
13.

Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients.

Sokol H, Pigneur B, Watterlot L, Lakhdari O, Bermúdez-Humarán LG, Gratadoux JJ, Blugeon S, Bridonneau C, Furet JP, Corthier G, Grangette C, Vasquez N, Pochart P, Trugnan G, Thomas G, Blottière HM, Doré J, Marteau P, Seksik P, Langella P.

Proc Natl Acad Sci U S A. 2008 Oct 28;105(43):16731-6. doi: 10.1073/pnas.0804812105. Epub 2008 Oct 20.

14.

Genes involved in obesity: Adipocytes, brain and microflora.

Macia L, Viltart O, Verwaerde C, Delacre M, Delanoye A, Grangette C, Wolowczuk I.

Genes Nutr. 2006 Sep;1(3-4):189-212. doi: 10.1007/BF02829968.

15.

Feeding our immune system: impact on metabolism.

Wolowczuk I, Verwaerde C, Viltart O, Delanoye A, Delacre M, Pot B, Grangette C.

Clin Dev Immunol. 2008;2008:639803. doi: 10.1155/2008/639803. Review.

16.

Lactobacillus fermentum ACA-DC 179 displays probiotic potential in vitro and protects against trinitrobenzene sulfonic acid (TNBS)-induced colitis and Salmonella infection in murine models.

Zoumpopoulou G, Foligne B, Christodoulou K, Grangette C, Pot B, Tsakalidou E.

Int J Food Microbiol. 2008 Jan 15;121(1):18-26. Epub 2007 Nov 6.

PMID:
18077037
17.

Impact of lactic Acid bacteria on dendritic cells from allergic patients in an experimental model of intestinal epithelium.

Ratajczak C, Duez C, Grangette C, Pochard P, Tonnel AB, Pestel J.

J Biomed Biotechnol. 2007;2007(1):71921. Epub 2007 Feb 28.

18.

Functional analysis of D-alanylation of lipoteichoic acid in the probiotic strain Lactobacillus rhamnosus GG.

Perea Vélez M, Verhoeven TL, Draing C, Von Aulock S, Pfitzenmaier M, Geyer A, Lambrichts I, Grangette C, Pot B, Vanderleyden J, De Keersmaecker SC.

Appl Environ Microbiol. 2007 Jun;73(11):3595-604. Epub 2007 Apr 13.

19.

A key role of dendritic cells in probiotic functionality.

Foligne B, Zoumpopoulou G, Dewulf J, Ben Younes A, Chareyre F, Sirard JC, Pot B, Grangette C.

PLoS One. 2007 Mar 21;2(3):e313.

20.

Correlation between in vitro and in vivo immunomodulatory properties of lactic acid bacteria.

Foligne B, Nutten S, Grangette C, Dennin V, Goudercourt D, Poiret S, Dewulf J, Brassart D, Mercenier A, Pot B.

World J Gastroenterol. 2007 Jan 14;13(2):236-43.

21.

Oral immunization of mice with lactic acid bacteria producing Helicobacter pylori urease B subunit partially protects against challenge with Helicobacter felis.

Corthésy B, Boris S, Isler P, Grangette C, Mercenier A.

J Infect Dis. 2005 Oct 15;192(8):1441-9. Epub 2005 Sep 13.

PMID:
16170763
22.

Enhanced antiinflammatory capacity of a Lactobacillus plantarum mutant synthesizing modified teichoic acids.

Grangette C, Nutten S, Palumbo E, Morath S, Hermann C, Dewulf J, Pot B, Hartung T, Hols P, Mercenier A.

Proc Natl Acad Sci U S A. 2005 Jul 19;102(29):10321-6. Epub 2005 Jun 28.

23.

Probiotics in IBD: mucosal and systemic routes of administration may promote similar effects.

Foligné B, Grangette C, Pot B.

Gut. 2005 May;54(5):727-8. No abstract available.

24.

Identification of Lactobacillus plantarum genes that are induced in the gastrointestinal tract of mice.

Bron PA, Grangette C, Mercenier A, de Vos WM, Kleerebezem M.

J Bacteriol. 2004 Sep;186(17):5721-9.

25.

Enhanced mucosal delivery of antigen with cell wall mutants of lactic acid bacteria.

Grangette C, Müller-Alouf H, Hols P, Goudercourt D, Delcour J, Turneer M, Mercenier A.

Infect Immun. 2004 May;72(5):2731-7.

26.

Knockout of the alanine racemase gene in Lactobacillus plantarum results in septation defects and cell wall perforation.

Palumbo E, Favier CF, Deghorain M, Cocconcelli PS, Grangette C, Mercenier A, Vaughan EE, Hols P.

FEMS Microbiol Lett. 2004 Apr 1;233(1):131-8.

27.

Mucosal co-application of lactic acid bacteria and allergen induces counter-regulatory immune responses in a murine model of birch pollen allergy.

Repa A, Grangette C, Daniel C, Hochreiter R, Hoffmann-Sommergruber K, Thalhamer J, Kraft D, Breiteneder H, Mercenier A, Wiedermann U.

Vaccine. 2003 Dec 8;22(1):87-95.

PMID:
14604575
28.

Impact of the Yersinia pseudotuberculosis-derived mitogen (YPM) on the murine immune system.

Carnoy C, Loiez C, Faveeuw C, Grangette C, Desreumaux P, Simonet M.

Adv Exp Med Biol. 2003;529:133-5. No abstract available.

PMID:
12756744
29.

Lactic acid bacteria inhibit TH2 cytokine production by mononuclear cells from allergic patients.

Pochard P, Gosset P, Grangette C, Andre C, Tonnel AB, Pestel J, Mercenier A.

J Allergy Clin Immunol. 2002 Oct;110(4):617-23.

PMID:
12373271
30.

Protection against tetanus toxin after intragastric administration of two recombinant lactic acid bacteria: impact of strain viability and in vivo persistence.

Grangette C, Müller-Alouf H, Geoffroy M, Goudercourt D, Turneer M, Mercenier A.

Vaccine. 2002 Sep 10;20(27-28):3304-9.

PMID:
12213400
31.

Lactic acid bacteria as live vaccines.

Mercenier A, Müller-Alouf H, Grangette C.

Curr Issues Mol Biol. 2000 Jan;2(1):17-25. Review.

32.

Mucosal immune responses and protection against tetanus toxin after intranasal immunization with recombinant Lactobacillus plantarum.

Grangette C, Müller-Alouf H, Goudercourt D, Geoffroy MC, Turneer M, Mercenier A.

Infect Immun. 2001 Mar;69(3):1547-53.

33.

The superantigenic toxin of Yersinia pseudotuberculosis: a novel virulence factor?

Carnoy C, Müller-Alouf H, Desreumaux P, Mullet C, Grangette C, Simonet M.

Int J Med Microbiol. 2000 Oct;290(4-5):477-82. Review.

PMID:
11111929
34.

Adaptation of the nisin-controlled expression system in Lactobacillus plantarum: a tool to study in vivo biological effects.

Pavan S, Hols P, Delcour J, Geoffroy MC, Grangette C, Kleerebezem M, Mercenier A.

Appl Environ Microbiol. 2000 Oct;66(10):4427-32.

35.

Influence of cold stress on the preliminary enrichment time needed for detection of enterohemorrhagic Escherichia coli in ground beef by PCR.

Uyttendaele M, Grangette C, Rogerie F, Pasteau S, Debevere J, Lange M.

Appl Environ Microbiol. 1998 May;64(5):1640-3.

36.
37.

Productive human immunodeficiency virus-1 infection of megakaryocytic cells is enhanced by tumor necrosis factor-alpha.

Monté D, Groux H, Raharinivo B, Plouvier B, Dewulf J, Clavel T, Grangette C, Torpier G, Auriault C, Capron A, et al.

Blood. 1992 May 15;79(10):2670-9.

38.

IgE receptor on human eosinophils (FcERII). Comparison with B cell CD23 and association with an adhesion molecule.

Grangette C, Gruart V, Ouaissi MA, Rizvi F, Delespesse G, Capron A, Capron M.

J Immunol. 1989 Dec 1;143(11):3580-8.

PMID:
2531185
39.

The second receptor for IgE in eosinophil effector function.

Capron M, Grangette C, Torpier G, Capron A.

Chem Immunol. 1989;47:128-78. Review. No abstract available.

PMID:
2532891
40.

IgE and inflammatory cells.

Capron A, Capron M, Grangette C, Dessaint JP.

Ciba Found Symp. 1989;147:153-60; discussion 160-70. Review.

PMID:
2515945

Supplemental Content

Loading ...
Support Center